Notably, IgG1 and IgG3 antibodies, potent activators of effector mechanisms, play a critical role in early response to viral infections (67) and have been found to correlate with advanced COVID-19 severity, age, and comorbidities (68–70). The gene discussed is IGHG3; the disease is viral infectious disease.